| Detailed Price Information Link | ||||||||||||||||
| BACTERIA |  How to read the following data (Example) | |||||||||||||||
| Name: | Pyxidicoccus fallax corrig. Reichenbach 2007 | |||||||||||||||
| DSM No.: | 51021 dsm-51021 dsm51021 dsm 51021 Pyxidicoccus fallax | |||||||||||||||
| Strain designation: | An d34, Py f2 | |||||||||||||||
| Isolated from: | soil | |||||||||||||||
| Country: | United States of America Utah, Colorado | |||||||||||||||
| Date of sampling: | before 09.07.2001 | |||||||||||||||
| Nagoya Protocol Restrictions: | There are NO known Nagoya Protocol restrictions for this strain. | |||||||||||||||
| History: | <- H. Reichenbach, GBF; Py f2 <- W. Dawid, Univ. Bonn | |||||||||||||||
| Cultivation conditions: | Medium 9 , 28°C Please follow special instructions: 'Reactivation of Myxobacteria from ampoules' Complete DSMZ Media List | |||||||||||||||
| Summary and additional information: | <- H. Reichenbach, GBF; Py f2 ; An d34<- W. Dawid, Univ. Bonn. Soil; USA, Utah, Colorado. Production of aspartokinase (6769). (Medium 9, 28°C [25°C-30°C]). | |||||||||||||||
| Literature: | 6769 | |||||||||||||||
| Risk group: | 1 (classification according to German TRBA) | |||||||||||||||
| Restrictions: | Commercial use and transfer to third parties is completely excluded for this strain. For a request for commercial use or a transfer please contact christiane.kuegler-walkemeyer@helmholtz-hzi.de | |||||||||||||||
| Supplied as: |
Freight and handling charges will be added. See price list. | |||||||||||||||
| Other cultures: | All DSMZ cultures of the species | |||||||||||||||
| Print data sheet | ||||||||||||||||
